Skip to main content
Janice Mehnert, MD, Oncology, New York, NY

JaniceMMehnertMD

Oncology New York, NY

Associate Director, Clinical Research Perlmutter Cancer Center of NYU Langone

Dr. Mehnert is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Mehnert's full profile

Already have an account?

  • Office

    160 E 34th St
    New York, NY 10016
    Phone+1 212-731-5431
    Fax+1 732-212-0713

Education & Training

  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 2004 - 2007
  • Icahn School of Medicine at Mount Sinai/Mount Sinai Hospital
    Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2001 - 2004
  • Rutgers Robert Wood Johnson Medical School
    Rutgers Robert Wood Johnson Medical SchoolClass of 2001

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2020 - 2025
  • NJ State Medical License
    NJ State Medical License 2007 - 2021
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Prognostic Gene Expression Profiling in Cutaneous Melanoma  
    Douglas Grossman, Sancy A Leachman, Larissa Korde, Elizabeth I Buchbinder, Emily Y Chu, Julia A Curtis, Laura K Ferris, Kenneth F Grossmann, Siwen Hu-Lieskovan, Joanne..., JAMA Dermatology
  • Autophagy Maintains Tumour Growth Through Circulating Arginine  
    Janice M Mehnert, Marcus W Bosenberg, Nature
  • The Challenge for Development of Valuable Immuno-Oncology Biomarkers  
    Arta M Monjazeb, Janice M Mehnert, Lyndsay N Harris, Clinical Cancer Research

Lectures

  • Immunotherapy Versus BRAF/MEK Inhibitors in the Adjvuant Setting: Is There a Clear Winner? 
    ASCO Annual Meeting 2019 - Chicago, IL - 6/2/2019

Authored Content

  • Prognostic Gene Expression Profiling in Cutaneous MelanomaJuly 2020
  • Prognostic Gene Expression Profiling in Cutaneous MelanomaJuly 2020
  • Prognostic Gene Expression Profiling in Cutaneous MelanomaJuly 2020

Press Mentions

  • Perlmutter Cancer Center Appoints New Clinical Trials Leadership, Expands Access to Early-Stage Trials
    Perlmutter Cancer Center Appoints New Clinical Trials Leadership, Expands Access to Early-Stage TrialsJuly 21st, 2022
  • Pembrolizumab May Help Prevent Early-Stage Melanoma from Returning
    Pembrolizumab May Help Prevent Early-Stage Melanoma from ReturningOctober 13th, 2021
  • New Cancer-Killing Virus Therapy Shows Promise Against Inoperable Skin Cancers
    New Cancer-Killing Virus Therapy Shows Promise Against Inoperable Skin CancersMay 24th, 2021
  • Join now to see all